Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 5/20 | 0.39 |
| ▸ | ACHE | P22303 | 4/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7769114 | 0.89 | CYP2C19 (0.46) | CYP2C19LMNAKMT2A | |
| SCHEMBL8749863 | 0.82 | CYP2C19 (0.61) | CYP2C19LMNAKMT2AFAAH | |
| SCHEMBL9622341 | 0.82 | CYP2C19 (0.61) | CYP2C19LMNAKMT2AFAAH | |
| SCHEMBL7045940 | 0.82 | CYP2C19 (0.61) | CYP2C19LMNAKMT2AFAAH | |
| SCHEMBL9621846 | 0.82 | CYP2C19 (0.55) | CYP2C19LMNAKMT2AFAAH | |
| SCHEMBL7799794 | 0.81 | CYP2C19 (0.62) | CYP2C19LMNAKMT2AFAAH | |
| SCHEMBL8838995 | 0.81 | CYP2C19 (0.62) | CYP2C19LMNAKMT2AFAAH | |
| SCHEMBL7773269 | 0.80 | CYP2C19 (0.50) | CYP2C19LMNAKMT2A | |
| SCHEMBL9507072 | 0.79 | CYP2C19 (0.65) | CYP2C19LMNAKMT2A | |
| SCHEMBL9302983 | 0.79 | SMN1; SMN2 (0.42) | CYP2C19LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0517326-B1 | Labeled drug hapten analogues for immunoassays | JOHNSON & JOHNSON CLIN DIAG (US) | 2001-08-16 | — | — | EP | disclosed |